2. GPCR/G Protein Immunology/Inflammation
  3. CXCR
  4. Ulocuplumab

Ulocuplumab  (Synonyms: 乌洛鲁单抗; BMS 936564; MDX 1338; Anti-Human CXCR4 Recombinant Antibody)

目录号: HY-P99272 纯度: 99.90%
COA

摩尔计算器

Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) 是一种完全人 IgG4 抗 CXCR4 抗体。Ulocplumab 诱导癌细胞凋亡 (apoptosis)，能够抑制 CXCL12 介导的慢性淋巴细胞白血病 (CLL) 细胞在 CXCR4 激活下的迁移。Ulocplumab 在急性髓系白血病 (AML)，非霍奇金淋巴瘤 (NHL) 和多发性骨髓瘤移植模型中显示抗肿瘤活性。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

CAS No. : 1375830-34-4

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥3000
In-stock
5 mg ￥7800
In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

Customer Review

Ulocuplumab 相关抗体

Top Publications Citing Use of Products

查看 CXCR 亚型特异性产品:

查看所有亚型
CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CXCR6

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models[1][2].

同型

Human IgG4 kappa
推荐同型对照抗体
种属

Human
IC50 & Target[1][2]

CXCR4

 

体外研究
(In Vitro)

Ulocplumab (0-100 μM; 48 h) 缺乏抗体依赖的细胞细胞毒性 (ADCC) 或补体 (CDC) 活性，但也在 Ramos 细胞和 CLL 或癌细胞系中诱导 CXCR4 结合介导的凋亡，也在 CLL 患者的原发性白血病细胞中显示促凋亡[1]。
Ulocplumab (0.2 μM, 2 μM; 15 s) 抑制 F-actin 聚合，降低对 CXCL12 的峰响应，(20 nM-2 μM; 1 h) 还抑制细胞迁移[1]。
Ulocplumab (200 nM; 6 h) 具有独立于 caspase 的程序性细胞死亡 (PCD) 诱导作用[1]。
Ulocplumab (10 μg/mL; 4 h) 在CLL细胞中通过产生活性氧 (ROS) 诱导细胞死亡[1]。
Ulocplumab 抑制 CXCL12 诱导的钙通量，在 Ramos 中 EC50 为 10 nM [2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Ulocuplumab 相关抗体:

Apoptosis Analysis[1]

Cell Line: Ramos cells and primary leukemia cells (from CLL patients)
Concentration: 0-100 μM
Incubation Time: 48 hours
Result: Induced apoptosis in Ramos cells with an IC50 value of 1.9 nM and showed pro-apoptotic with an IC50 value of 12.43 nM in primary leukemia cells from CLL patients.
体内研究
(In Vivo)

Ulocplumab (3-30 mg/kg; 腹腔注射; 3-4 天 5 次剂量; 共 65 天) 抑制小鼠多发性骨髓瘤异种移植瘤模型的肿瘤生长，包括带有 Ramos B 细胞、HL-60 细胞、MOLP-8 细胞、Nomo-1 细胞和 JJN-3R 细胞的肿瘤模型[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Severe combined immunodeficient (SCID) mice of AML model (MOLP-8 cells)[1]
Dosage: 3-30 mg/kg
Administration: Intraperitoneal injection; every 3-4 days for 5 doses; last for 65 days
Result: Significantly delayed mean tumor growth by 66% and 56% when compared with isotype control on day 25.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

乌洛鲁单抗
运输条件

Shipping with dry ice.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG4 kappa
Biological Activity
  • Immobilized Human CXCR4/CD184 Protein can bind Ulocuplumab. The EC50 for this effect is 47.58 ng/mL.
纯度 & 产品资料
参考文献

Ulocuplumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Ulocuplumab1375830-34-4BMS 936564 MDX 1338 Anti-Human CXCR4 Recombinant Antibody乌洛鲁单抗BMS936564BMS-936564MDX1338MDX 1338MDX-1338CXCRCXC chemokine receptorsC-X-C motif chemokine receptorsIgG4chronic lymphocytic leukemiaCLLcell migrationRamos B cellsHL-60 cellsMOLP-8 cellsNomo-1 cellsJJN-3R cellsInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Ulocuplumab
目录号：
HY-P99272
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z